Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Max V. Ranall et al.|Cancer Research|2018Cited by 43
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Jennifer R. Grandis, Rex H. Lee et al.|JCI Insight|2021Cited by 19
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M. Brand, Jennifer R. Grandis, Stefan Hartmann et al.|Cancer Research|2022Cited by 5